NCT05091580Suspended
Effectiveness and Cost-Effectiveness of Depression Treatment for Individuals With TB in South Africa
The Effectiveness and Cost-effectiveness of Implementing Evidence-based Depression Treatment Within the TB Care Platform in South Africa: A Hybrid Effectiveness-implementation Trial
Source: ClinicalTrials.gov · Last updated 26 Aug 2026
Brief summary (registry, in English)
This hybrid type I effectiveness-implementation trial will increase understanding of the effectiveness and cost-effectiveness of integrating a brief evidence-based treatment for major depressive disorder (MDD) within the tuberculosis (TB) care platform to improve TB and MDD. Findings from this R01 are likely to inform policy and treatment guidelines for the integrated management of TB and MDD in low- and middle-income countries globally.
- Status (registry)
- Suspended
- Study type
- Interventional
- Enrollment
- 500 (estimated)
- First submitted
- 28 Sept 2021
- Start date
- 24 Mar 2023
- Primary completion date
- 31 Jul 2028
- Lead sponsor
- New York State Psychiatric Institute
- Diseases
- Tuberculosis
- NCT number
- NCT05091580
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- unable or unwilling to provide informed consent
Who the study is looking for
- 18 years or over
- initiating treatment for TB
- ability to provide informed consent
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Desmond Tutu Health Foundation | Cape Town | South Africa | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.